Home Health States’ Inconsistent Monitoring of Peptides Poses Risks

States’ Inconsistent Monitoring of Peptides Poses Risks

States’ Inconsistent Monitoring of Peptides Poses Risks

An investigation by NBC News highlights a lack of consistent monitoring for the risks associated with peptides across states. Many states have varying policies, creating a patchwork approach to oversight. Experts caution that allowing compounding pharmacies to produce certain peptides will still fall short of providing the necessary regulation.

Peptides monitoring

In February, Sarah Moran experienced severe side effects after taking a popular peptide. Her symptoms included a racing heart when standing and dizziness that persisted for several days.

Leave a Reply

Your email address will not be published.